Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and morbidity of sacrocolpopexy: Robot (RASC) vs Laparoscopy (LSC), A retrospective, monocentric multi-departmental study.

Journal of gynecology obstetrics and human reproduction·2026
Same author

Investigating the trend of revisional bariatric surgery, the complications, and associated risk factors in France.

International journal of obesity (2005)·2026
Same author

Effect of sleeve gastrectomy on distal esophagus at 5 and 10 years.

Surgical endoscopy·2024
Same author

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.

International journal of surgery (London, England)·2024
Same author

Unplanned readmissions after hernia repair.

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

Double origin of an occlusion after gastric bypass: Intestinal intussusception contained in a Petersen hernia.

Journal of visceral surgery·2023
Same journal

Robotic radical anterogradepancreatosplenectomy (r-RAMPS)(with video).

Journal of visceral surgery·2026
Same journal

Pancreatodudenectomy versus total pancreatectomy in patients at high risk of pancreatic fistula: A systematic review of the literature.

Journal of visceral surgery·2026
Same journal

Re: "Aorto-duodenal fistula: what should we do?"

Journal of visceral surgery·2026
Same journal

Transgastric singleport laparoscopic resection of a gastroesophageal junction stromal tumor (with video).

Journal of visceral surgery·2026
Same journal

Revascularization of the hepatic artery by reimplantation of the gastroduodenal artery during a pancreatoduodenectomy (with video).

Journal of visceral surgery·2026
Same journal

Surgery is no longer the only effective treatment for obesity: What does this means?

Journal of visceral surgery·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Sporadic primary hyperparathyroidism.

C Blanchard1, E Mirallié, M Mathonnet

  • 1Clinique de chirurgie digestive et endocrine, institut des maladies de l'appareil digestif, Hôtel-Dieu, CHU de Nantes, 44093 Nantes cedex 1, France.

Journal of Visceral Surgery
|October 5, 2010
PubMed
Summary
This summary is machine-generated.

Primary hyperparathyroidism (HPT1) is a common endocrine disorder, often asymptomatic. Surgical intervention offers the only cure, with high success rates indicated by intraoperative parathormone (PTH) level decrease.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Related Experiment Videos

Last Updated: Jun 8, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Area of Science:

  • Endocrinology
  • Surgical Oncology

Background:

  • Primary hyperparathyroidism (HPT1) is a prevalent endocrine disorder, frequently asymptomatic.
  • Diagnosis relies on elevated parathormone (PTH) levels amid hypercalcemia.
  • Uniglandular disease accounts for 85% of HPT1 cases, with multiglandular disease in the remainder.

Purpose of the Study:

  • To outline the diagnostic and management strategies for primary hyperparathyroidism.
  • To emphasize the curative role of surgery and its various approaches.
  • To discuss the predictive factors for surgical success and the management of persistent disease.

Main Methods:

  • Localization studies including MIBI scintigraphy and neck ultrasound (sensitivity >95%).
  • Surgical approaches: bilateral exploration, unilateral, minimally invasive video-assisted, or endoscopic.
  • Intraoperative PTH level monitoring to predict surgical cure.

Main Results:

  • A >50% intraoperative PTH decrease predicts cure in over 97% of cases.
  • Surgery is recommended even for moderate HPT1 and elderly patients, improving quality of life and bone density.
  • Persistent or recurrent HPT1 necessitates expert management; persistent postoperative PTH elevation without hypercalcemia requires no further exploration.

Conclusions:

  • Surgery is the definitive treatment for primary hyperparathyroidism.
  • Minimally invasive surgical techniques and intraoperative PTH monitoring enhance outcomes.
  • Management of persistent or recurrent disease requires specialized care, with uncertain prognosis in some normocalcemic postoperative cases.